Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac Booster Immunogenicity and Safety in Adults and Elderly
NCT05329038Phase 4Active, not recruiting
- Sponsor
- Sinovac Life Sciences
- Start
- Apr 2022
- Primary completion
- Jun 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Life Sciences. Started Apr 2022; status: active, not recruiting.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05329038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329038.